Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bessho

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|June 27, 1998
[Two cases of hematological malignancies diagnosed before death as aspergillosis with skin lesion]M Fukuda, K Tominaga, K Endo, et al.
International Journal of Cell Cloning|November 1, 1990
Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemiaM Bessho, I Jinnai, A Matsuda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 28, 1999
[The importance of WT1 gene expression in the detection of minimal residual disease. A comparison of WT1 AML1/MTG8 transcripts]S Kusumoto, I Murohashi, M Bessho, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 7, 2002
[Clinical significance of WHO classification and MDS 2000 classification in myelodysplastic syndromes]M Akiba, A Matsuda, M Misumi, et al.
International Journal of Cell Cloning|November 1, 1984
Relationship between fibroblastoid colony-forming units (CFU-f) and hemopoietic precursor cells in normal human bone marrowI Jinnai, M Bessho, I Murohashi, et al.
Oncogene|December 5, 1996
BRCA1 protein level is not affected by peptide growth factors in MCF10A cell lineO Aprelikova, A Kuthiala, M Bessho, et al.
Journal of the National Cancer Institute|September 24, 1999
Biologic and biochemical analyses of p16(INK4a) mutations from primary tumorsW G Yarbrough, R A Buckmire, M Bessho, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|September 21, 2005
I kappa B-mediated apoptotic gene therapy against acute myelogenous leukemia using replication-defective HSV-1 vector expressing TK and mutant I kappa B alphaY Kuwayama, T Suzuki, S Moriuchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2007
Clinicopathologic correlations of stage IE/IIE primary thyroid diffuse large B-cell lymphomaN Niitsu, M Okamoto, N Nakamura, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1984
Leukemia-derived growth factor (non-interleukin-2) produced by murine lymphoma T-cell linesE F Hays, D Goodrum, M Bessho, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|June 27, 1998
[Two cases of hematological malignancies diagnosed before death as aspergillosis with skin lesion]M Fukuda, K Tominaga, K Endo, et al.
International Journal of Cell Cloning|November 1, 1990
Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemiaM Bessho, I Jinnai, A Matsuda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 28, 1999
[The importance of WT1 gene expression in the detection of minimal residual disease. A comparison of WT1 AML1/MTG8 transcripts]S Kusumoto, I Murohashi, M Bessho, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 7, 2002
[Clinical significance of WHO classification and MDS 2000 classification in myelodysplastic syndromes]M Akiba, A Matsuda, M Misumi, et al.
International Journal of Cell Cloning|November 1, 1984
Relationship between fibroblastoid colony-forming units (CFU-f) and hemopoietic precursor cells in normal human bone marrowI Jinnai, M Bessho, I Murohashi, et al.
Oncogene|December 5, 1996
BRCA1 protein level is not affected by peptide growth factors in MCF10A cell lineO Aprelikova, A Kuthiala, M Bessho, et al.
Journal of the National Cancer Institute|September 24, 1999
Biologic and biochemical analyses of p16(INK4a) mutations from primary tumorsW G Yarbrough, R A Buckmire, M Bessho, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|September 21, 2005
I kappa B-mediated apoptotic gene therapy against acute myelogenous leukemia using replication-defective HSV-1 vector expressing TK and mutant I kappa B alphaY Kuwayama, T Suzuki, S Moriuchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2007
Clinicopathologic correlations of stage IE/IIE primary thyroid diffuse large B-cell lymphomaN Niitsu, M Okamoto, N Nakamura, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1984
Leukemia-derived growth factor (non-interleukin-2) produced by murine lymphoma T-cell linesE F Hays, D Goodrum, M Bessho, et al.
Pageof 9